Print…

Procaspase-3 Ativador (PAC1, (4-Benzilpiperazina)ácido acético-(3-allil-2-hidroxibenzilideno)hidrazina) ≥98% (por HPLC), Sigma-Aldrich®

Fornecedor: Merck
Atenção

Sinônimos: 4-(Phenylmethyl)[[2-hydroxy-3-(2-propenyl)phenyl]methylene]hydrazide-1-piperazine acetic acid, (4-benzylpiperazino)acetic acid-(3-allyl-2-hydroxybenzylidene)hydrazide

Nível de qualidade M-Clarity™ = MQ100

P0115-25MG P0115-5MG
SIALP0115-25MGEA 591 EUR
SIALP0115-25MG SIALP0115-5MG
Procaspase-3 Ativador (PAC1, (4-Benzilpiperazina)ácido acético-(3-allil-2-hidroxibenzilideno)hidrazina) ≥98% (por HPLC), Sigma-Aldrich®
Procaspase-3-activator (PAC1, (4-benzylpiperazino)acetic acid-(3-allyl-2-hydroxybenzylidene)hydrazide)

PAC-1 is a caspase 3 activator.


Caspase activation is a key strategy in cancer therapy. Caspase 3 is a key executioner caspase and direct effector of apoptosis. Hallmark of many cancers is the circumvention of signal in the activation of executioner caspases and loss of apoptotic response. EC50 for caspase 3 activation = 0.33 μM and caspase 7= 4.5 μM. The IC50 for apoptosis induction = 0.92 μM. Elevated caspase 3 level in cancerous cell lines and tissues allows PAC-1 to selectively induce apoptosis in tissues.

Fórmula: C₂₃H₂₈N₄O₂
Peso Molecular: 392.49 g/mol
Temperatura de Armazenamento: Frigorífico
Número MDL : MFCD03302441
Número CAS: 315183-21-2

Encomendar


Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Mais info About VWR